Home › Proteinuria › Pennsylvania
Proteinuria clinical trials in Pennsylvania
5 studies for Proteinuria are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Temple University, Philadelphia
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Oct 1, 2026 · NCT05268289A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #30, Bethlehem
- Investigator Site #19, Bridgeville
- Investigator Site #22, Butler
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Childrens Hospital of Philadelphia, Philadelphia
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
- Univ of Pennsylvania Medical Center, Philadelphia
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Jul 13, 2026 · NCT05755386Empagliflozin Treatment in Kidney Transplant Recipients
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Apr 21, 2026 · NCT06013865From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.